drug-information.ru

|Liothyronine Sodium

Drugs search, click the first letter of a drug name:

| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 2 | 3 | 4 | 5 | 6 | 8 | 9 Home

Liothyronine Sodium

( T ₃ ; triiodothyronine ) Pronouncation: (lie-oh-THIGH-row-neen SO-deeuhm)
Class: Thyroid hormone

Trade Names:
Cytomel
- Tablets 5 mcg
- Tablets 25 mcg
- Tablets 50 mcg

Trade Names:
Triostat
- Injection 10 mcg/mL

Mechanism of Action

Pharmacology

Increases metabolic rate of body tissues; is needed for normal growth and maturation.

Pharmacokinetics

Absorption

95% absorbed.

Distribution

Protein binding is more than 99%.

Elimination

Biological t _½ is 2.5 days.

Onset

Within a few hr.

Peak

Within 2 to 3 days.

Indications and Usage

Replacement or supplemental therapy in hypothyroidism; TSH suppression for treatment or prevention of euthyroid goiters (eg, thyroid nodules, multinodular goiters, enlargement in chronic thyroiditis); diagnostic agent in suppression tests to differentiate suspected hyperthyroidism from euthyroidism; treatment of myxedema coma/precoma (IV).

Contraindications

Acute MI and thyrotoxicosis uncomplicated by hypothyroidism; coexistence of hypothyroidism and hypoadrenalism (Addison disease), unless treatment of hypoadrenalism with adrenocortical steroids precedes initiation of thyroid therapy.

Dosage and Administration

Individualize dosage.

Hypothyroidism
Adults

PO 25 mcg/day initially, increase by up to 25 mcg q 1 to 2 wk if needed.

Children

PO 5 mcg/day initially, increase by 5 mcg/day at 2 wk intervals, if needed.

Congenital Hypothyroidism
Children

PO 5 mcg/day initially; increase by 5 mcg/day every 3 to 4 days until desired response achieved. Infants a few mo of age may require only 20 mcg/day for maintenance; at 1 yr, 50 mcg/day may be required; and, above 3 yr, full adult dosage may be required.

Simple (Nontoxic) Goiter
Adults

PO 5 mcg/day initially, increase by 5 to 10 mcg q 1 to 2 wk. When 25 mcg/day is reached, increase by 12.5 to 25 mcg q 1 to 2 wk if needed.

Children

PO 5 mcg/day initially, increase by 5 mcg/day at 2-wk intervals, if needed.

Myxedema
Adults

PO 5 mcg/day initially, increase by 5 to 10 mcg q 1 to 2 wk. When 25 mcg/day is reached, increase by 12.5 to 25 mcg q 1 to 2 wk if needed.

Children

PO 5 mcg/day initially, increase by 5 mcg/day at 2-wk intervals, if needed.

Myxedema Coma/Precoma
Adults

IV 25 to 50 mcg initially. In patients with known or suspected cardiovascular disease, an initial dose of 10 to 20 mcg is suggested; however, base doses on continuous monitoring of the condition and response to therapy.

TSH Suppression Test
Adults

PO 75 to 100 mcg/day for 7 days.

Storage/Stability

Store tablets in tightly closed container at controlled room temperature (59° to 86°F); store injection in refrigerator (36° to 46°F).

Drug Interactions

Anticoagulants, oral

May increase anticoagulant effects.

Beta blockers

May reduce effects of beta blockers.

Cholestyramine, colestipol

May decrease thyroid hormone efficacy.

Digitalis glycosides

May reduce effects of glycosides.

Theophyllines

Hypothyroidism; may cause decreased theophylline clearance; Cl may return to normal when euthyroid state is achieved.

Laboratory Test Interactions

Consider changes in thyroxine-binding globulin concentration when interpreting thyroxine (T ₄ ) and triiodothyronine (T ₃ ) values; medicinal or dietary iodine interferes with all in vivo tests of radioiodine uptake, producing low uptakes that may not reflect true decrease in hormone synthesis.

Adverse Reactions

Cardiovascular

Palpitations; tachycardia; cardiac arrhythmias; angina pectoris; cardiac arrest.

CNS

Tremors; headache; nervousness; insomnia.

GI

Diarrhea; vomiting.

Miscellaneous

Hypersensitivity; weight loss; menstrual irregularities; sweating; heat intolerance; fever; decreased bone density (in women using drug long term).

Precautions

Warnings

Not for use in obesity treatment. Ineffective for weight reduction indications and may produce life-threatening or serious consequences when used in large doses or in combination with other anorectics.

Pregnancy

Category A .

Lactation

Minimal amounts excreted in breast milk.

Children

When drug is administered for congenital hypothyroidism, routine determinations of serum T ₄ or TSH are strongly advised in newborns. In infants, excessive doses of thyroid hormone preparations may produce craniosynostosis. Children may experience transient partial hair loss in first few months of thyroid therapy.

Elderly

Therapy should be started with 5 mcg q day and increased by 5 mcg increments at recommended intervals.

Cardiovascular disease

Use caution when integrity of cardiovascular system, particularly coronary arteries, is suspect (eg, angina, elderly). Development of chest pain or worsening cardiovascular disease requires decrease in dosage.

Endocrine disorders

Therapy in patients with concomitant diabetes mellitus, diabetes insipidus, or adrenal insufficiency (Addison disease) exacerbates intensity of their symptoms. Therapy of myxedema coma requires simultaneous administration of glucocorticoids. Use corticosteroids to correct adrenal insufficiency in patients whose hypothyroidism is secondary to hypopituitarism.

Hyperthyroid effects

Liothyronine may rarely precipitate hyperthyroid state or may aggravate existing hyperthyroidism.

Infertility

Drug is unjustified for treatment of male or female infertility unless condition is accompanied by hypothyroidism.

Morphologic hypogonadism and nephrosis

Rule out before therapy.

Myxedema coma

Patients are particularly sensitive to thyroid preparations. Sudden administration of large doses is not without cardiovascular risks. Small initial doses are indicated.

Overdosage

Symptoms

Symptoms of hyperthyroidism: Headache, irritability, nervousness, sweating, tachycardia, increased bowel motility, menstrual irregularities, palpitations, vomiting, psychosis, seizure, fever, angina pectoris, CHF, shock, arrhythmias, thyroid storm.

Patient Information

Instruct patient to take liothyronine as directed. Do not change or discontinue dosage without consulting health care provider. Explain that liothyronine does not cure hypothyroidism and that therapy will continue for rest of life.
Instruct patient with diabetes mellitus to closely monitor urinary glucose levels. The daily dosage of antidiabetic medication may need readjustment as thyroid hormone replacement is achieved or if thyroid medication is stopped.
Explain that partial hair loss may be experienced by children in first few months of therapy, but that this side effect is transient.
Advise patient to wear Medi-Alert bracelet or necklace and to carry Medi-Alert card in wallet.
Inform patient that liothyronine"s effects are more rapid than levothyroxine, which requires several days before onset of action.
Teach patient to take pulse and inform the health care provider if signs of tachycardia or dysrhythmias occur.
Instruct patient to call the health care provider immediately if any adverse symptoms such as chest pain, palpitations, headaches, irritability, increased nervousness, diaphoresis, tachycardia, dysrhythmias, or heat intolerance occur.
Inform patient of possible adverse reactions with other drugs or foods they may be taking. Caution patient to inform health care provider of any drugs, including OTC drugs, they may be taking or planning to take.
Emphasize the importance of follow-up examinations and periodic laboratory tests.
Caution patient not to take liothyronine for weight control.

Where can I get more information about Liothyronine Sodium ? We recommend to use www.Drugs.com

Typical mistypes for Liothyronine Sodium
kiothyronine sodium, piothyronine sodium, oiothyronine sodium, luothyronine sodium, ljothyronine sodium, lkothyronine sodium, loothyronine sodium, l9othyronine sodium, l8othyronine sodium, liithyronine sodium, likthyronine sodium, lilthyronine sodium, lipthyronine sodium, li0thyronine sodium, li9thyronine sodium, liorhyronine sodium, liofhyronine sodium, lioghyronine sodium, lioyhyronine sodium, lio6hyronine sodium, lio5hyronine sodium, liotgyronine sodium, liotbyronine sodium, liotnyronine sodium, liotjyronine sodium, liotuyronine sodium, liotyyronine sodium, liothtronine sodium, liothgronine sodium, liothhronine sodium, liothuronine sodium, lioth7ronine sodium, lioth6ronine sodium, liothyeonine sodium, liothydonine sodium, liothyfonine sodium, liothytonine sodium, liothy5onine sodium, liothy4onine sodium, liothyrinine sodium, liothyrknine sodium, liothyrlnine sodium, liothyrpnine sodium, liothyr0nine sodium, liothyr9nine sodium, liothyrobine sodium, liothyromine sodium, liothyrojine sodium, liothyrohine sodium, liothyronune sodium, liothyronjne sodium, liothyronkne sodium, liothyronone sodium, liothyron9ne sodium, liothyron8ne sodium, liothyronibe sodium, liothyronime sodium, liothyronije sodium, liothyronihe sodium, liothyroninw sodium, liothyronins sodium, liothyronind sodium, liothyroninr sodium, liothyronin4 sodium, liothyronin3 sodium, liothyronine aodium, liothyronine zodium, liothyronine xodium, liothyronine dodium, liothyronine eodium, liothyronine wodium, liothyronine sidium, liothyronine skdium, liothyronine sldium, liothyronine spdium, liothyronine s0dium, liothyronine s9dium, liothyronine sosium, liothyronine soxium, liothyronine socium, liothyronine sofium, liothyronine sorium, liothyronine soeium, liothyronine soduum, liothyronine sodjum, liothyronine sodkum, liothyronine sodoum, liothyronine sod9um, liothyronine sod8um, liothyronine sodiym, liothyronine sodihm, liothyronine sodijm, liothyronine sodiim, liothyronine sodi8m, liothyronine sodi7m, liothyronine sodiun, liothyronine sodiuk, liothyronine sodiuj, iothyronine sodium, lothyronine sodium, lithyronine sodium, liohyronine sodium, liotyronine sodium, liothronine sodium, liothyonine sodium, liothyrnine sodium, liothyroine sodium, liothyronne sodium, liothyronie sodium, liothyronin sodium, liothyroninesodium, liothyronine odium, liothyronine sdium, liothyronine soium, liothyronine sodum, liothyronine sodim, liothyronine sodiu, ilothyronine sodium, loithyronine sodium, litohyronine sodium, liohtyronine sodium, liotyhronine sodium, liothryonine sodium, liothyornine sodium, liothyrnoine sodium, liothyroinne sodium, liothyronnie sodium, liothyronien sodium, liothyronin esodium, liothyronines odium, liothyronine osdium, liothyronine sdoium, liothyronine soidum, liothyronine soduim, liothyronine sodimu, lliothyronine sodium, liiothyronine sodium, lioothyronine sodium, liotthyronine sodium, liothhyronine sodium, liothyyronine sodium, liothyrronine sodium, liothyroonine sodium, liothyronnine sodium, liothyroniine sodium, liothyroninne sodium, liothyroninee sodium, liothyronine sodium, liothyronine ssodium, liothyronine soodium, liothyronine soddium, liothyronine sodiium, liothyronine sodiuum, liothyronine sodiumm, etc.